What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - Groups Biomedical Research in Gynaecology Professionals Sonja Brandt Professionals Carlos Petrola Chacón Cirurgià General i Digestiu format a l'Hospital Universitari Vall d'Hebron amb àrea d'interès a la Cirurgia Endocrina, Bariàtrica i Metabòlica mínimament invasives. Professionals Thomas Mortimer Oliver Thomas Mortimer, Ph.D., is a Junior Group Leader at VHIR where he heads the recently established Circadian Rhythms and Ageing Laboratory. Dr. Mortimer began his academic career at the Francis Crick Institute in the laboratory of Dr. Paola Scaffidi, where, during his doctorate, he studied the epigene Professionals Anabel Sacristan Ruiz Professionals Pamela Dominguez Baez I have more than 3 years of experience in the research sector. I am a person who is passionate about his work, I like to work in a team and generate a good work environment, I am orderly, with initiative, communicative, rigorous, meticulous, curious, decisive, flexible, proactive, innovative, consta Year 2026 Títol Complet Suministro, instalación, configuración y puesta en marcha de un repositorio de datos centralizado e interoperable destinado a dar soporte a las actividades de gestión, almacenamiento y análisis de datos de la Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR) a cargo del proyecto BRIDGE (Breaking Barriers with Remote Integration for Global Pediatric Trials), financiado por el Instituto de Salud Carlos III (ISCIII) y por los fondos Next Generation EU que financian las actuaciones del Mecanismo para la Recuperación y la Resiliencia (MRR). Expedient REPOSITORIO DE DATOS CON CAPACIDADES DE INTERCONEX Codi 24989804 Documentos (enllaços) ANUNCIO DE LICITACIÓN PLIEGO DE CLÁUSULAS ADMINISTRATIVAS PARTICULARES Anexos PCAP PLIEGO DE PRESCRIPCIONES TÉCNICAS Anexo 1 PPT - Proyecto ejecutvio Anexo 2 PPT INSTRUCCIONES PARA RELLENAR EL DEUC PRINCIPALES PUNTOS SOBRE DIGITAL ACUERDO DE NECESIDAD CERTIFICADO DE EXISTENCIA DE CRÉDITO RESOLUCIÓN DE APROBACIÓN DEL EXPEDIENTE RESOLUCIÓN DESIGNACIÓN MESA DE CONTRATACIÓN ANUNCIO DE LICITACIÓN PLIEGO DE CLÁUSULAS ADMINISTRATIVAS PARTICULARES Anexos PCAP PLIEGO DE PRESCRIPCIONES TÉCNICAS INSTRUCCIONES PARA RELLENAR EL DEUC PRINCIPALES PUNTOS SOBRE DIGITAL ACUERDO DE NECESIDAD CERTIFICADO DE EXISTENCIA DE CRÉDITO RESOLUCIÓN DE APROBACIÓN DEL EXPEDIENTE RESOLUCIÓN DESIGNACIÓN MESA DE CONTRATACIÓN A phase 2, randomized, placebo-controlled, double-blind clinical study to evaluate efficacy and safety of LAD603 in adult subjects with severe to very severe alopecia areata Contact Protocol code: M-00223-20 EudraCT code: No aplica Pathology: Malalties de la pell i del teixit subcutani Principal investigator: Cabezas Calderón, Victor Service: Dermatologia Phase: Fase II Recruiting: Closed Status: Iniciat Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio en dos fases, aleatorizado, doble ciego y controlado con placebo en el que se evalúan la eficacia, la seguridad y la farmacocinética de alpelisib en pacientes adultos y pediátricos con malformaciones linfáticas asociadas a la mutación en PIK3CA Contact Protocol code: CBYL719P12201 EudraCT code: _ Pathology: Malalties del sistema nerviós Principal investigator: Camprodon Gomez, Maria Research group: Malalties neurodegeneratives Service: Medicina Interna Phase: Fase III Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio aleatorizado de fase 3, doble ciego y controlado conplacebo, diseñado para evaluar la eficacia y seguridad de la eloralintida administradauna vez por semana en adultos con obesidad persistente o sobrepeso tratados conuna incretina semanal, con o sin diabetes tipo 2 (ENLIGHTEN-6) Contact Protocol code: J3R-MC-YDAL EudraCT code: No aplica Pathology: Malalties endocrines, nutricionals i metabòliques Principal investigator: Ciudin Mihai, Andreea Research group: Diabetis i metabolisme Service: Endocrinologia Phase: Phase III Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de fase I//Ib, abierto, multicéntrico de BMS-986506 en participantes con carcinoma renal de células claras (ccRCC) avanzado Contact Protocol code: CA242-0001 EudraCT code: No aplica Pathology: Tumors Principal investigator: De la Paz Cañizares, Isabel Service: Hematologia i Hematoteràpia Phase: Fase I Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Ensayo de fase 3, multicéntrico, aleatorizado, doble ciego ycontrolado con placebo para evaluar la eficacia y la seguridad de mezagitamab (TAK-079) en combinación con tratamiento de base estable en participantes del estudio connefropatía por IgA primaria Contact Protocol code: TAK-079-3001 EudraCT code: No aplica Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més Principal investigator: Agraz Pamplona, Irene Research group: Nefrologia i trasplantament renal Service: Nefrologia Phase: Phase III Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A Phase 3, Randomized, Double-blind, Placebo-controlled, 3-Part Study to Evaluate the Efficacy and Safety of Orally Administered Deucrictibant XR Tablet for Prophylaxis and Deucrictibant Soft Capsule for On-demand Treatment of Angioedema Attacks in Adults with Acquired Angioedema due to C1 Inhibitor Deficiency (CREAATE) Contact Protocol code: PHA022121-C308 EudraCT code: No aplica Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified Principal investigator: Guilarte Clavero, Mar Research group: Malalties sistèmiques Service: Internal Medicine Phase: Phase III Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Pulmonary Hypertension Patients with Heart Failure with Preserved Left Ventricular Ejection Fraction Contact Protocol code: TNX-103-07 EudraCT code: No aplica Pathology: Malalties del sistema respiratori Principal investigator: Soriano Colomé, Toni Research group: Malalties cardiovasculars Service: Cardiologia Phase: Phase III Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. CLEOPATTRA: efectos de NNC6019-0001 en comparación con placebo en losresultados cardiovasculares de participantes con miocardiopatía amiloide portranstirretina (MC-ATTR) Contact Protocol code: NN6019-4958 EudraCT code: No aplica Pathology: Malalties del sistema circulatori Principal investigator: Martínez Valle, Fernando Research group: Systemic Diseases Service: Internal Medicine Phase: Phase III Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de fase 2b, aleatorizado, doble ciego y controlado con placebo para evaluar la eficacia y la seguridad de tulisokibart en participantes con artritis psoriásica. Contact Protocol code: MK-7240-015 EudraCT code: No aplica Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified Principal investigator: ERRA DURAN, M Alba Research group: Reumatologia Service: Reumatologia Phase: Phase II Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Ensayo en fase IIb//III, abierto y multicéntrico para evaluar la eficacia y la seguridaddel cambio a brelovitug para el tratamiento de la hepatitis D crónica en participantes quereciben bulevirtida (AZURE-3) Contact Protocol code: BJT-778-303 EudraCT code: No aplica Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified Principal investigator: Buti Ferret, Maria Research group: Malalties hepàtiques Service: Hepatologia Phase: Phase III Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de fase III aleatorizado, doble ciego, controlado conplacebo y multicéntrico de nipocalimab en adultos con lupus eritematoso sistémico demoderado a grave Contact Protocol code: 80202135SLE3001 EudraCT code: No aplica Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified Principal investigator: Cortes Hernandez, Josefina Research group: Rheumatology Service: Rheumatology Phase: Phase III Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio adaptativo de intervención, aleatorizado con doble enmascaramiento y grupos paralelos, de dosis flexibles y comparativo con placebo para evaluar la eficacia de KL1333 en pacientes adultos con enfermedad mitocondrial primaria Contact Protocol code: KL 1333 2020-104A EudraCT code: No aplica Pathology: Nervous system diseases Principal investigator: Juntas Morales, Raul Research group: Sistema nerviós perifèric Service: Neurologia Phase: Phase II Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A phase III, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of once-weekly RO7795068 administered to participants with obesity or overweight and type 2 diabetes Contact Protocol code: WC45726 EudraCT code: 2025-523106-32-00 Pathology: Endocrine, nutritional and metabolic diseases Principal investigator: Ciudin Mihai, Andreea Research group: Diabetes and Metabolism Service: Endocrinology Phase: Phase III Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Pagination First page « Previous page ‹ … Page 260 Page 261 Current page 262 Page 263 Page 264 … Next page › Last page »
Year 2026 Títol Complet Suministro, instalación, configuración y puesta en marcha de un repositorio de datos centralizado e interoperable destinado a dar soporte a las actividades de gestión, almacenamiento y análisis de datos de la Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR) a cargo del proyecto BRIDGE (Breaking Barriers with Remote Integration for Global Pediatric Trials), financiado por el Instituto de Salud Carlos III (ISCIII) y por los fondos Next Generation EU que financian las actuaciones del Mecanismo para la Recuperación y la Resiliencia (MRR). Expedient REPOSITORIO DE DATOS CON CAPACIDADES DE INTERCONEX Codi 24989804 Documentos (enllaços) ANUNCIO DE LICITACIÓN PLIEGO DE CLÁUSULAS ADMINISTRATIVAS PARTICULARES Anexos PCAP PLIEGO DE PRESCRIPCIONES TÉCNICAS Anexo 1 PPT - Proyecto ejecutvio Anexo 2 PPT INSTRUCCIONES PARA RELLENAR EL DEUC PRINCIPALES PUNTOS SOBRE DIGITAL ACUERDO DE NECESIDAD CERTIFICADO DE EXISTENCIA DE CRÉDITO RESOLUCIÓN DE APROBACIÓN DEL EXPEDIENTE RESOLUCIÓN DESIGNACIÓN MESA DE CONTRATACIÓN ANUNCIO DE LICITACIÓN PLIEGO DE CLÁUSULAS ADMINISTRATIVAS PARTICULARES Anexos PCAP PLIEGO DE PRESCRIPCIONES TÉCNICAS INSTRUCCIONES PARA RELLENAR EL DEUC PRINCIPALES PUNTOS SOBRE DIGITAL ACUERDO DE NECESIDAD CERTIFICADO DE EXISTENCIA DE CRÉDITO RESOLUCIÓN DE APROBACIÓN DEL EXPEDIENTE RESOLUCIÓN DESIGNACIÓN MESA DE CONTRATACIÓN
